0

PF-04217329

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP1005549949
CAS1005549-94-9
Molecular Weight520.60
Description≥98% (HPLC)
SolubilityDMSO: 2 mg/mL, clear
Assay≥98% (HPLC)
Colorwhite to beige
Formpowder
Size5MG, 25MG
Storage Conditionsroom temp
1

A Phase 2, Randomized, Dose-Response Trial of Taprenepag Isopropyl (PF-04217329) Versus Latanoprost 0.005% in Open-Angle Glaucoma and Ocular Hypertension

Ronald A Schachar, Susan Raber, Rachel Courtney, Min Zhang

Curr Eye Res. 2011 Sep;36(9):809-17.

PMID: 21851167

1

Effect of PF-04217329 a Prodrug of a Selective Prostaglandin EP(2) Agonist on Intraocular Pressure in Preclinical Models of Glaucoma

Ganesh Prasanna, Samantha Carreiro, Scott Anderson, Hovhannes Gukasyan, Soisurin Sartnurak, Husam Younis, David Gale, Cathie Xiang, Peter Wells, Dac Dinh, Chau Almaden, Jay Fortner, Carol Toris, Michael Niesman, etc.

Exp Eye Res. 2011 Sep;93(3):256-64.

PMID: 21376717

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode